Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.
Hoban D, Felmingham D. Hoban D, et al. J Antimicrob Chemother. 2002 Sep;50 Suppl S1:49-59. doi: 10.1093/jac/dkf810. J Antimicrob Chemother. 2002. PMID: 12239228 Clinical Trial.
Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007.
Farrell DJ, Felmingham D, Shackcloth J, Williams L, Maher K, Hope R, Livermore DM, George RC, Brick G, Martin S, Reynolds R; BSAC Working Parties on Resistance Surveillance. Farrell DJ, et al. Among authors: felmingham d. J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii87-95. doi: 10.1093/jac/dkn355. J Antimicrob Chemother. 2008. PMID: 18819983
The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae.
Farrell DJ, Felmingham D. Farrell DJ, et al. J Antimicrob Chemother. 2005 Oct;56(4):795-7. doi: 10.1093/jac/dki282. Epub 2005 Aug 9. J Antimicrob Chemother. 2005. PMID: 16091419 No abstract available.
BSAC Respiratory Resistance Surveillance Programme (2002-2003): comparative susceptibility of Streptococcus pneumoniae, cultured from patients in Great Britain and Ireland with community-acquired lower respiratory tract infection, to gemifloxacin.
Felmingham D, Shackcloth J, Tillotson G. Felmingham D, et al. J Antimicrob Chemother. 2004 Sep;54(3):698-9. doi: 10.1093/jac/dkh394. Epub 2004 Aug 4. J Antimicrob Chemother. 2004. PMID: 15294888 No abstract available.
PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea.
Inoue M, Lee NY, Hong SW, Lee K, Felmingham D. Inoue M, et al. Int J Antimicrob Agents. 2004 Jan;23(1):44-51. doi: 10.1016/j.ijantimicag.2003.07.002. Int J Antimicrob Agents. 2004. PMID: 14732313 Clinical Trial.
Molecular characterization and antimicrobial susceptibility of fluoroquinolone-resistant or -susceptible Streptococcus pneumoniae from Hong Kong.
Morrissey I, Farrell DJ, Bakker S, Buckridge S, Felmingham D. Morrissey I, et al. Antimicrob Agents Chemother. 2003 Apr;47(4):1433-5. doi: 10.1128/aac.47.4.1433-1435.2003. Antimicrob Agents Chemother. 2003. PMID: 12654686 Free PMC article.
The need for antimicrobial resistance surveillance.
Felmingham D. Felmingham D. J Antimicrob Chemother. 2002 Sep;50 Suppl S1:1-7. doi: 10.1093/jac/dkf807. J Antimicrob Chemother. 2002. PMID: 12239224 Review.
Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Felmingham D, et al. J Antimicrob Chemother. 2002 Sep;50 Suppl S1:25-37. doi: 10.1093/jac/dkf808. J Antimicrob Chemother. 2002. PMID: 12239226 Clinical Trial.
123 results
Jump to page